Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 21367-21368 [2011-9165]
Download as PDF
<![CDATA[
21367
Federal Register / Vol. 76, No. 73 / Friday, April 15, 2011 / Notices
than thirty days after the date of this
Notice. If any person wishes to
comment concerning the termination of
the receivership, such comment must be
made in writing and sent within thirty
days of the date of this Notice to:
Federal Deposit Insurance Corporation,
Attention: Receivership Oversight
Department 8.1, 1601 Bryan Street,
Dallas, Texas 75201.
No comments concerning the
termination of these receiverships will
be considered which are not sent within
this time frame.
Dated: April 11, 2011.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
[FR Doc. 2011–9127 Filed 4–14–11; 8:45 am]
BILLING CODE 6714–01–P
FEDERAL DEPOSIT INSURANCE
CORPORATION
Update to Notice of Financial
Institutions for Which the Federal
Deposit Insurance Corporation Has
Been Appointed Either Receiver,
Liquidator, or Manager
Federal Deposit Insurance
Corporation.
ACTION: Update Listing of Financial
Institutions in Liquidation.
AGENCY:
Notice is hereby given that
the Federal Deposit Insurance
Corporation (Corporation) has been
appointed the sole receiver for the
following financial institutions effective
as of the Date Closed as indicated in the
listing. This list (as updated from time
SUMMARY:
to time in the Federal Register) may be
relied upon as ‘‘of record’’ notice that the
Corporation has been appointed receiver
for purposes of the statement of policy
published in the July 2, 1992 issue of
the Federal Register (57 FR 29491). For
further information concerning the
identification of any institutions which
have been placed in liquidation, please
visit the Corporation Web site at https://
www.fdic.gov/bank/individual/failed/
banklist.html or contact the Manager of
Receivership Oversight in the
appropriate service center.
Dated: April 11, 2011.
Federal Deposit Insurance Corporation.
Pamela Johnson,
Regulatory Editing Specialist.
INSTITUTIONS IN LIQUIDATION
[In alphabetical order]
FDIC Ref. No.
Bank name
City
State
10351 .................................................
10352 .................................................
Nevada Commerce Bank ..................
Western Springs National Bank and
Trust.
Las Vegas .........................................
Western Springs ................................
NV ........
IL ..........
BILLING CODE 6714–01–P
indirectly acquire voting shares of
Coconut Grove Bank, both of Miami,
Florida.
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
Board of Governors of the Federal Reserve
System, April 12, 2011.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 2011–9166 Filed 4–14–11; 8:45 am]
srobinson on DSKHWCL6B1PROD with NOTICES
[FR Doc. 2011–9158 Filed 4–14–11; 8:45 am]
BILLING CODE 6210–01–P
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than May 2,
2011.
A. Federal Reserve Bank of Atlanta
(Clifford Stanford, Vice President) 1000
Peachtree Street, N.E., Atlanta, Georgia
30309:
1. Phillip Frost, Miami Beach, Florida;
to acquire voting shares of Coconut
Grove Bankshares, Inc., and thereby
VerDate Mar<15>2010
16:58 Apr 14, 2011
Jkt 223001
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Date closed
04/08/2011
04/08/2011
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than May 12, 2011.
A. Federal Reserve Bank of New York
(Ivan Hurwitz, Vice President) 33
Liberty Street, New York, New York
10045–0001:
1. China Investment Corporation and
Central Huijin Investment Limited, both
in Beijing, China; to become bank
holding companies by indirectly
acquiring 80 percent of the voting shares
of The Bank of East Asia (U.S.A.)
National Association, New York, New
York.
2. Industrial and Commercial Bank of
China Limited, Beijing, China; to
become a bank holding company by
acquiring 80 percent of the voting shares
of The Bank of East Asia (U.S.A.)
National Association, New York, New
York.
E:\FR\FM\15APN1.SGM
15APN1
21368
Federal Register / Vol. 76, No. 73 / Friday, April 15, 2011 / Notices
Board of Governors of the Federal Reserve
System, April 12, 2011.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 2011–9165 Filed 4–14–11; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES (HHS)
Evaluation of the Potential
Developmental Effects of Cancer
Chemotherapy During Pregnancy: Call
for Information and Nomination of
Scientific Experts
National Institute of
Environmental Health Sciences
(NIEHS); National Toxicology Program;
National Institutes of Health (NIH),
HHS.
ACTION: Call for information and
nomination of scientific experts.
AGENCY:
CERHR is evaluating the
scientific evidence regarding the
potential developmental effects of
cancer chemotherapy during pregnancy.
CERHR invites the submission of
information about ongoing studies or
upcoming publications on the
pregnancy outcomes and long-term
health of offspring exposed to cancer
chemotherapy agents during pregnancy
and associated topics that might be
considered for inclusion in the
evaluation. CERHR also invites the
nomination of scientific experts to
potentially serve as technical advisors
in conducting the evaluation or as
members of an ad hoc expert panel to
be convened to peer review the draft
Monograph on Cancer Chemotherapy
during Pregnancy (see SUPPLEMENTARY
INFORMATION). The peer review meeting
is tentatively scheduled for August 29–
30, 2011 at the NIEHS. When set, the
date and location of the meeting will be
announced in the Federal Register and
posted on the CERHR Website (https://
cerhr.niehs.nih.gov). The peer review
meeting will be open to the public with
time scheduled for oral public
comment.
DATES: All information and nominations
should be received by May 16, 2011.
ADDRESSES: Information and
nominations may be submitted to Dr.
Kembra Howdeshell, CERHR, NTP,
NIEHS, P.O. Box 12233, MD K2–04,
Research Triangle Park, NC 27709
(mail), 919–316–4708 (telephone), or
howdeshellkl@niehs.nih.gov (email).
Courier address: NIEHS, 530 Davis
Drive, Room K2161, Morrisville, NC
27560.
SUPPLEMENTARY INFORMATION:
srobinson on DSKHWCL6B1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:58 Apr 14, 2011
Jkt 223001
Background
A significant number of pregnant
women are diagnosed with cancer each
year. The frequency of such diagnoses is
difficult to determine, but has been
estimated to be between 1 in 1000 to 1
in 6000 pregnancies. Treatment for
cancer most often involves some form of
chemotherapy. The United States Food
and Drug Administration has
categorized nearly all chemotherapy
agents as Pregnancy Category D, i.e.,
investigational or post-marketing data
show risk to the fetus. The evidence for
risk for health effects from exposure to
the chemotherapeutic agents usually
comes from studies in laboratory
animals. The general medical opinion
on chemotherapy use during pregnancy
is that it should be avoided in the first
trimester and that treatment during the
second and third trimesters, with the
exception of a few chemotherapy agents,
presents minimal risk to the fetus.
While some reviews have been
published in the medical literature on
pregnancy outcomes following
chemotherapy during pregnancy, the
majority of these reviews focus on
specific cancer types or specific
chemotherapeutic agents. Thus, CERHR
proposes to conduct a comprehensive
survey of the literature and
systematically evaluate the scientific
evidence regarding the developmental
toxicity of cancer chemotherapy during
pregnancy in humans for the six most
frequently diagnosed cancers in
pregnant women, i.e., lymphoma,
leukemia, and cancers of the breast,
ovary, skin, and cervix. This review will
evaluate a large literature, including
more than 700 papers and
approximately 40 chemotherapeutic
agents, available on pregnancy
outcomes in humans following
chemotherapy. The CERHR evaluation
will include studies of individual, as
well as combinations of, chemotherapy
agents and the period of gestation in
which they are administered. The
document should provide clinicians,
patients, and researchers with a
comprehensive review of the incidence
and types of adverse effects observed in
humans exposed in utero to cancer
chemotherapy. While CERHR recognizes
that some chemotherapeutic agents are
also used to treat non-cancer health
conditions of pregnant women, the
focus of the proposed evaluation is on
cancer chemotherapy. The NTP Board of
Scientific Counselors (BSC) discussed
the CERHR evaluation of developmental
effects of cancer chemotherapy on June
21, 2010 (75 FR 21003). BSC meeting
minutes are available at https://
ntp.niehs.nih.gov/go/9741.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Request for Information
CERHR invites the public and other
interested parties to submit information
on cancer chemotherapy during
pregnancy, including data on pregnancy
outcomes, long-term health reports of
human offspring, and laboratory animal
toxicology information from completed,
ongoing, or planned studies. This
information will be considered in
evaluating the potential developmental
effects of exposure to cancer
chemotherapy during pregnancy.
Information should be submitted to
CERHR (see ADDRESSES).
Request for Nomination of Scientific
Experts
CERHR invites nominations of
qualified scientists (i.e., basic scientists,
clinicians, and toxicologists) to serve as
technical advisors and/or as members of
an ad hoc expert panel to peer review
the draft NTP Monograph on Cancer
Chemotherapy during Pregnancy.
Scientists serving as technical advisors
or on the peer review panel should
represent a wide range of expertise
including, but not limited to:
developmental biology, developmental
toxicology, epidemiology, medicine
(e.g., obstetrics, oncology, and
pediatrics), neurotoxicology,
pharmacokinetics, reproductive
toxicology, renal toxicology, and
biostatistics. Technical advisors and
expert panel members should meet
criteria to serve as an expert including,
but not limited to, formal academic
training and experience in a relevant
scientific field, publications in peerreviewed journals, and membership in
relevant professional societies.
Nomination should include contact
information and current curriculum
vitae (if possible) and be forwarded to
CERHR (see ADDRESSES). Final selection
of individuals to serve on the peer
review panel will be made in
accordance with the Federal Advisory
Committee Act and Department of
Health and Human Services
implementing regulations. All technical
advisors and panel members serve as
individual experts and not as
representatives of their employers or
other organizations.
Background Information on CERHR
The NTP established CERHR in 1998
(63 FR 68782). CERHR is a publicly
accessible resource for information
about adverse reproductive and/or
developmental health effects associated
with exposure to environmental and/or
occupational exposures. CERHR
publishes monographs that assess the
evidence regarding whether
E:\FR\FM\15APN1.SGM
15APN1
]]>Agencies
[Federal Register Volume 76, Number 73 (Friday, April 15, 2011)]
[Notices]
[Pages 21367-21368]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-9165]
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and Mergers of Bank Holding
Companies
The companies listed in this notice have applied to the Board for
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C.
1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other
applicable statutes and regulations to become a bank holding company
and/or to acquire the assets or the ownership of, control of, or the
power to vote shares of a bank or bank holding company and all of the
banks and nonbanking companies owned by the bank holding company,
including the companies listed below.
The applications listed below, as well as other related filings
required by the Board, are available for immediate inspection at the
Federal Reserve Bank indicated. The application also will be available
for inspection at the offices of the Board of Governors. Interested
persons may express their views in writing on the standards enumerated
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the
acquisition of a nonbanking company, the review also includes whether
the acquisition of the nonbanking company complies with the standards
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted,
nonbanking activities will be conducted throughout the United States.
Unless otherwise noted, comments regarding each of these
applications must be received at the Reserve Bank indicated or the
offices of the Board of Governors not later than May 12, 2011.
A. Federal Reserve Bank of New York (Ivan Hurwitz, Vice President)
33 Liberty Street, New York, New York 10045-0001:
1. China Investment Corporation and Central Huijin Investment
Limited, both in Beijing, China; to become bank holding companies by
indirectly acquiring 80 percent of the voting shares of The Bank of
East Asia (U.S.A.) National Association, New York, New York.
2. Industrial and Commercial Bank of China Limited, Beijing, China;
to become a bank holding company by acquiring 80 percent of the voting
shares of The Bank of East Asia (U.S.A.) National Association, New
York, New York.
[[Page 21368]]
Board of Governors of the Federal Reserve System, April 12,
2011.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 2011-9165 Filed 4-14-11; 8:45 am]
BILLING CODE 6210-01-P
